ProQR Therapeutics N.V. Ordinary Shares

PRQR

...

PRQR: ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Show PRQR Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of PRQR by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by PRQR's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on PRQR's company Twitter account

WallStreetBets

Number of mentions of PRQR in WallStreetBets Daily Discussion

PRQR News

Recent insights relating to PRQR

CNBC Recommendations

Recent picks made for PRQR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PRQR

Corporate Flights

Flights by private jets registered to PRQR